Susana Banerjee

Ontology type: schema:Person     

Person Info





Publications in SciGraph latest 50 shown

  • 2019-02 Imaging in the pre-operative staging of ovarian cancer in ABDOMINAL RADIOLOGY
  • 2019-02 Reply to ‘Physician burnout: let’s avoid unsubstantiated claims’ in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2019-01 Let’s address burnout in oncologists and reimagine the way we work in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2018-12 Microenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticity in NATURE COMMUNICATIONS
  • 2017-12 The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole in BMC CANCER
  • 2017-05 Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2016-09 Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients in SCIENTIFIC REPORTS
  • 2015-12 Quantitative histology analysis of the ovarian tumour microenvironment in SCIENTIFIC REPORTS
  • 2015 Neoadjuvant and Adjuvant Chemotherapy for Advanced Ovarian Cancer, Including Biological Agents in PELVIC CANCER SURGERY
  • 2013-06 Personalized Therapy in Gynecological Cancer: A Reality in Clinical Practice? in CURRENT ONCOLOGY REPORTS
  • 2013-06 Patients’ and oncologists’ views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study in BRITISH JOURNAL OF CANCER
  • 2012-12 Progression-Free Survival Versus Overall Survival in Ovarian Cancer: Where Are We Now? in CURRENT ONCOLOGY REPORTS
  • 2012-04 Gynecological cancer: First-line bevacizumab for ovarian cancer—new standard of care? in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2011-12 PARP Inhibitors in BRCA Gene-Mutated Ovarian Cancer and Beyond in CURRENT ONCOLOGY REPORTS
  • 2010-10-23 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs in EMERGING THERAPEUTIC TARGETS IN OVARIAN CANCER
  • 2010-09 Making the best of PARP inhibitors in ovarian cancer in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2007-09 Mechanisms of Disease: angiogenesis and the management of breast cancer in NATURE REVIEWS CLINICAL ONCOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "", 
        "affiliation": [
            "affiliation": {
              "id": "", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
        "familyName": "Banerjee", 
        "givenName": "Susana", 
        "id": "sg:person.01326353035.21", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:55", 
        "sdLicense": "", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_641.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' ''

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' ''

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' ''

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' ''


    Preview window. Press ESC to close (or click here)